Effect of Autogenic Training on Hemodialysis Patients
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 55 years old?
Source: NCT07276828, who can take part
Where in Egypt
- Faculity of physical therapyCairo, EgyptContact: Zainab Khamis, M.sc studentNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT07276828
- Record updated
- 22 December 2025
- Original description
goal of this interventional study to investigate the effect of autogenic training on sleep disturbance , restless leg syndrome and fatigue on hemodialysis patient Is there any significant effect of autogenic training on restless leg syndrome, sleep disturbance and fatigue in patients with hemodialysis?Read full original descriptionShow less
Effect Of Autogenic Training On Restless Leg Syndrome And Sleep Disturbance In Hemodialysis
goal of this interventional study to investigate the effect of autogenic training on sleep disturbance , restless leg syndrome and fatigue on hemodialysis patient Is there any significant effect of autogenic training on restless leg syndrome, sleep disturbance and fatigue in patients with hemodialysis?
The intervention will include structured autogenic training sessions, and outcomes such as sleep quality and RLS severity and fatigue will be evaluated after 8 weeks of autogenic training on hemodialysis patients .
Inclusion: Age between 45 and 55 years; Body Mass Index (BMI) between 25.0 and 29.9 kg/m²; Clinically and medically stable; On hemodialysis for at least 6 months prior to enrollment; Diagnosed with chronic kidney disease (CKD), defined by one or more of the following:; Evidence of kidney damage (e.g., albuminuria), or; Decreased kidney function with glomerular filtration rate (GFR) < 60 mL/min/1.73 m² for ≥ 3 months, irrespective of clinical diagnosis; *Systolic blood pressure < 140 mmHg, diastolic blood pressure < 90 mmHg, and heart rate < 80 bpm.
Exclusion: Uncontrolled pulmonary disease; Unstable angina; Uncontrolled cardiac arrhythmia; Decompensated heart failure; Cognitive impairment; Severe vascular complications (e.g., critical limb ischemia); Participants who miss more than two weeks of the program or request termination.